Physician profile
James D Dunn
NPI 1659332815
$2,250.19
in general payments reported to CMS, 2019-2025
23 companies · $48.28 in 2025
The $48.28 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $234 · 2021: $293 · 2022: $551 · 2023: $703 · 2024: $126 · 2025: $48.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $510 · Food and Beverage: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $509.79 |
| Food and Beverage | $367.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $577.02 | 2019-2023 | Da Vinci Surgical System |
| Braintree Laboratories, INC. | $500.18 | 2019-2023 | Sutab, Suflave |
| Conmed Corporation | $223.37 | 2021-2022 | |
| Medtronic, INC. | $176.95 | 2022 | |
| Acera Surgical, INC. | $153.33 | 2023 | Restrata Wound Matrix |
| Medtronic USA, INC. | $144.47 | 2020 | |
| Olympus America INC. | $97.72 | 2019 | |
| Boston Scientific Corporation | $68.69 | 2024 | Spyglass Discover |
| Innovation Technologies INC | $38.00 | 2024 | Irrisept |
| Convatec INC. | $34.04 | 2020 | |
| Osiris Therapeutics INC. | $25.74 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $24.84 | 2025 | |
| Tela Bio, INC. | $23.44 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Hollister Incorporated | $22.32 | 2022 | |
| Axonics, INC. | $21.54 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $19.58 | 2024 | |
| Heron Therapeutics, INC. | $18.08 | 2021 | |
| Smith+Nephew, INC. | $16.63 | 2020 | |
| Daiichi Sankyo INC. | $14.79 | 2023 | Injectafer |
| Mallinckrodt Hospital Products INC. | $13.37 | 2020 | |
| Baudax Bio INC. | $12.61 | 2020 | |
| Ethicon US, LLC | $11.83 | 2021 | |
| Mallinckrodt Enterprises LLC | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Dunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.